Table 1.
Sex, females: n, % | 4, 44.4% |
Age, years: mean (SD) | 46.9 (10.3) |
Age at onset, years: mean (SD) | 13.2 (6.3) |
Number of prior ASDs: median (IQR) | 3 (3–5) |
ASDs combined to LCM (n) | VPA (6), LEV (4), LTG (1) |
VPA dose, mg: median (IQR)a | 1250 (1050–1450) |
Number of GTCS/6 months pre-LCM: median (IQR) | 2 (2–3) |
Excluding patients not taking VPA.